5VM
SKYE icon

5AM Venture Management’s Skye Bioscience SKYE Stock Holding History

5AM Venture Management’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Hold
1,210,220
– – 2.33% 13
2026
Q1 		$5.95M Hold
1,210,220
– – 1.65% 18
2025
Q4 		$7.26M Hold
1,210,220
– – 2.28% 18
2025
Q3 		$38M Sell
1,210,220
-28,926
-2% -$874K 13.94% 1
2025
Q2 		$41.4M Hold
1,239,146
– – 15.93% 1
2025
Q1 		$15.8M Hold
1,239,146
– – 5.96% 4
2024
Q4 		$28.1M Hold
1,239,146
– – 6.69% 3
2024
Q3 		$38.8M Sell
1,239,146
-33,292
-3% -$1.49M 8.01% 3
2024
Q2 		$81.5M Buy
+1,272,438
New +$121M 18.24% 1

Other funds holding SKYE

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

5AM Venture Management's SKYE Position: Q2 2026 in Review

5AM Venture Management held its Skye Bioscience (SKYE) position steady in Q2 2026 at 1,210,220 shares worth $6.71M. The position accounts for 2.33% of the portfolio, ranked #13.

5AM Venture Management first reported a position in SKYE in Q2 2024 and has held it in 9 quarters since. The position peaked at $81.5M in Q2 2024. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • 5AM Venture Management held 1,210,220 shares of Skye Bioscience worth $6.71M as of Q2 2026.
  • 5AM Venture Management left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up 2.33% of 5AM Venture Management's portfolio in Q2 2026, its #13 holding.
  • 5AM Venture Management first reported a position in Skye Bioscience in Q2 2024 and has held it in 9 quarters since.
  • 5AM Venture Management's Skye Bioscience position peaked at $81.5M in Q2 2024.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on 5AM Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.